GR861086B - Method for the preparation of imidazoquinoline antithrombogenic cardiotonic agents - Google Patents

Method for the preparation of imidazoquinoline antithrombogenic cardiotonic agents

Info

Publication number
GR861086B
GR861086B GR861086A GR860101086A GR861086B GR 861086 B GR861086 B GR 861086B GR 861086 A GR861086 A GR 861086A GR 860101086 A GR860101086 A GR 860101086A GR 861086 B GR861086 B GR 861086B
Authority
GR
Greece
Prior art keywords
imidazoquinoline
antithrombogenic
preparation
cardiotonic agents
cardiotonic
Prior art date
Application number
GR861086A
Other languages
Greek (el)
English (en)
Inventor
Meanwell A Nicholas
Wright J John
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GR861086B publication Critical patent/GR861086B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR861086A 1985-04-25 1986-04-24 Method for the preparation of imidazoquinoline antithrombogenic cardiotonic agents GR861086B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (1)

Publication Number Publication Date
GR861086B true GR861086B (en) 1986-09-01

Family

ID=27111398

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861086A GR861086B (en) 1985-04-25 1986-04-24 Method for the preparation of imidazoquinoline antithrombogenic cardiotonic agents

Country Status (32)

Country Link
US (1) US4668686A (cg-RX-API-DMAC7.html)
KR (1) KR940000828B1 (cg-RX-API-DMAC7.html)
CN (1) CN1016175B (cg-RX-API-DMAC7.html)
AT (1) AT390257B (cg-RX-API-DMAC7.html)
AU (1) AU592983B2 (cg-RX-API-DMAC7.html)
BE (1) BE904671A (cg-RX-API-DMAC7.html)
CA (1) CA1298836C (cg-RX-API-DMAC7.html)
CH (1) CH675722A5 (cg-RX-API-DMAC7.html)
CY (1) CY1641A (cg-RX-API-DMAC7.html)
DE (1) DE3614132A1 (cg-RX-API-DMAC7.html)
DK (3) DK164868C (cg-RX-API-DMAC7.html)
EG (1) EG18104A (cg-RX-API-DMAC7.html)
ES (3) ES8708229A1 (cg-RX-API-DMAC7.html)
FI (1) FI83316C (cg-RX-API-DMAC7.html)
FR (1) FR2581065B1 (cg-RX-API-DMAC7.html)
GB (1) GB2174987B (cg-RX-API-DMAC7.html)
GR (1) GR861086B (cg-RX-API-DMAC7.html)
HK (1) HK64492A (cg-RX-API-DMAC7.html)
HU (1) HU195813B (cg-RX-API-DMAC7.html)
IL (1) IL78581A0 (cg-RX-API-DMAC7.html)
IT (1) IT1215651B (cg-RX-API-DMAC7.html)
LU (1) LU86406A1 (cg-RX-API-DMAC7.html)
MY (1) MY102086A (cg-RX-API-DMAC7.html)
NL (1) NL8601053A (cg-RX-API-DMAC7.html)
NO (1) NO163406C (cg-RX-API-DMAC7.html)
NZ (1) NZ215885A (cg-RX-API-DMAC7.html)
OA (1) OA08242A (cg-RX-API-DMAC7.html)
PT (1) PT82460B (cg-RX-API-DMAC7.html)
SE (1) SE461468B (cg-RX-API-DMAC7.html)
SG (1) SG29092G (cg-RX-API-DMAC7.html)
SU (3) SU1450746A3 (cg-RX-API-DMAC7.html)
YU (1) YU46054B (cg-RX-API-DMAC7.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
NZ266525A (en) * 1993-07-06 1997-10-24 Pfizer 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine derivatives and medicaments
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
US6664264B2 (en) * 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
CA2535120A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
KR101106812B1 (ko) 2003-08-27 2012-01-19 쓰리엠 이노베이티브 프로퍼티즈 컴파니 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
WO2005032484A2 (en) * 2003-10-03 2005-04-14 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1682544A4 (en) * 2003-11-14 2009-05-06 3M Innovative Properties Co HYDROXYLAMINE SUBSTITUTED IMIDAZO RING COMPOUNDS
CN1906193A (zh) 2003-11-14 2007-01-31 3M创新有限公司 肟取代的咪唑环化合物
SG148201A1 (en) 2003-11-25 2008-12-31 3M Innovative Properties Co Substituted imidazo ring systems and methods
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
CA2559863A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
MX2007003078A (es) * 2004-09-14 2007-05-16 Novartis Vaccines & Diagnostic Compuestos de imidazoquinolina.
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
PL2583970T3 (pl) 2006-08-02 2016-05-31 Cytokinetics Inc Określone cząstki chemiczne, kompozycje i sposoby zawierające imidazopirymidyny
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
EP2139478A4 (en) * 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
PH12014500094A1 (en) 2011-07-13 2014-03-17 Cytokinetics Inc Combination als therapy
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
HU195813B (en) 1988-07-28
IT8620206A0 (it) 1986-04-24
CY1641A (en) 1992-11-06
DK165248B (da) 1992-10-26
AU592983B2 (en) 1990-02-01
CN86102747A (zh) 1987-02-04
ES557552A0 (es) 1988-07-16
YU116787A (en) 1988-04-30
FI83316B (fi) 1991-03-15
NL8601053A (nl) 1986-11-17
DK190986D0 (da) 1986-04-24
DK165249B (da) 1992-10-26
FR2581065A1 (fr) 1986-10-31
IL78581A0 (en) 1986-08-31
KR860008177A (ko) 1986-11-12
GB8610037D0 (en) 1986-05-29
BE904671A (fr) 1986-10-24
DK80291D0 (da) 1991-04-30
SU1450746A3 (ru) 1989-01-07
DK80291A (da) 1991-04-30
KR940000828B1 (ko) 1994-02-02
NO163406B (no) 1990-02-12
FI861684L (fi) 1986-10-26
FI83316C (fi) 1991-06-25
FR2581065B1 (fr) 1990-02-02
SU1470192A3 (ru) 1989-03-30
FI861684A0 (fi) 1986-04-22
MY102086A (en) 1992-03-31
NZ215885A (en) 1989-04-26
PT82460A (en) 1986-05-01
DE3614132A1 (de) 1986-11-27
LU86406A1 (fr) 1986-11-05
OA08242A (en) 1987-10-30
ES557551A0 (es) 1988-02-16
GB2174987B (en) 1989-08-02
IT1215651B (it) 1990-02-22
PT82460B (pt) 1988-11-30
ES8708229A1 (es) 1987-10-01
NO861617L (no) 1986-10-27
ES8801829A1 (es) 1988-02-16
SE8601907L (sv) 1986-10-26
SE461468B (sv) 1990-02-19
DK81091D0 (da) 1991-05-01
HUT42089A (en) 1987-06-29
HK64492A (en) 1992-09-04
YU46054B (sh) 1992-12-21
ES554336A0 (es) 1987-10-01
CA1298836C (en) 1992-04-14
SE8601907D0 (sv) 1986-04-24
CH675722A5 (cg-RX-API-DMAC7.html) 1990-10-31
DK164868C (da) 1993-01-11
SU1560056A3 (ru) 1990-04-23
AT390257B (de) 1990-04-10
ES8802521A1 (es) 1988-07-16
SG29092G (en) 1992-05-15
CN1016175B (zh) 1992-04-08
EG18104A (en) 1992-09-30
DK190986A (da) 1986-10-26
AU5641386A (en) 1986-10-30
NO163406C (no) 1990-05-23
DK164868B (da) 1992-08-31
DK165249C (da) 1993-03-22
GB2174987A (en) 1986-11-19
US4668686A (en) 1987-05-26
ATA112186A (de) 1989-09-15
DK81091A (da) 1991-05-01
DK165248C (da) 1993-03-22

Similar Documents

Publication Publication Date Title
GR861086B (en) Method for the preparation of imidazoquinoline antithrombogenic cardiotonic agents
GR861484B (en) Method for the preparation of active compounds
EP0311983A3 (en) Method for the preparation of titanium-silicalites
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
PT82226A (en) Process for the preparation of 3-aryluraciles and pesticeides therewith
PT83835A (en) Process for the preparation of new derivatives of calcitonine
PT81835B (en) Process for the preparation of spirodioxolanes spirodithiolanes and spirooxothiolanes
AR242395A1 (es) Procedimiento para la obtencion de derivados de la esfingosina.
GR862211B (en) Azolyl-cyclopropyl-ethanol derivatives methods for their preparation and their use
GR860082B (en) Method for the preparation of polycyclic salts
GR860950B (en) Method for the preparation of nitrofuranne derivatives
IL88163A0 (en) Method for the preparation of anilopiperidine derivatives
PH23235A (en) Combination preparations for the treatment of malaria
ZA876455B (en) Method for the preparation of anilinofumarate
PT83137A (en) Process for the preparation of cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
DE3661358D1 (en) Method for the preparation of 2-mercaptobenzoxazoles
GR860323B (en) Method for the preparation of 3-hydroxy -3-phenyl-piperidine derivatives
DE3660220D1 (en) Process for the preparation of chloronitroanilines and chloronitrophenols
GB2146016B (en) Method for the preparation of haloacetals and halodioxolanes
ZA887372B (en) Method for the preparation of anilinofumarate
ZA863029B (en) Imidazoquinoline antithrombogenic cardiotonic agents
GR860442B (en) Method for the preparation of benzoacid derivatives
DE3665866D1 (en) Method for silalactone preparation and use
GR82507B (en) Method for the preparation of pyrazolopyridine derivatives
EP0297447A3 (en) Method for the preparation of 2-cyclopentenones